Last updated: May 23, 2012
Chemistry and Biology: Partners in- Decoding the Genome
 | Chemistry and Biology: Partners in |
Monday, March 15, 2004 | |
| 8:30 - 8:45 a.m. | Welcome: Elias Zerhouni, Director, National Institutes of Health |
| 8:45 - 8:50 a.m. | Greetings from Sponsoring Institutes: Jeremy Berg, Director, National Institute of General Medical Sciences |
| Moderator: John Schwab National Institute of General Medical Sciences | |
| 8:50 - 9:15 a.m. | Christopher Austin, National Human Genome Research Institute Small Molecules and the NIH Roadmap |
| 9:15 - 9:55 a.m. | Daniel Kahne, Princeton University Glycopeptide Antibiotics and Cell Envelope Biogenesis |
| 9:55 - 10:35 a.m. | Stuart Schreiber, Harvard University Dissecting Disease Biology and Advancing Medicine with Small Molecules |
| 10:35 - 10:50 a.m. | Break |
| 10:50 - 11:30 a.m. | Craig Crews, Yale University A Small Molecule Approach to Target Identification and Validation |
| 11:30 - 12:10 p.m | Carolyn Bertozzi, University of California, Berkeley Chemical Approaches to Studying Protein Glycosylation |
| 12:10 - 1:00 p.m. | Lunch |
| Moderator: Christopher Austin National Human Genome Research Institute | |
| 1:00 - 1:40 p.m. | David Liu, Harvard University An Evolution-Based Approach to the Creation and Discovery of Functional Synthetic Molecules |
| 1:40 - 2:20 p.m. | Roger Tsien, University of California, San Diego Genetically and Proteolytically Targeted Sequences for Imaging from Ultrastructure to Whole Mammals |
| 2:20 - 3:00 p.m. | Jeremy Berg, Director, National Institute of General Medical Sciences Chemical Approaches to Zinc Finger Protein Analysis and Design |
| 3:00 - 3:20 p.m. | Break |
| 3:20 - 4:00 p.m. | Jon Ellman, University of California, Berkeley Combinatorial Chemistry Targeting Protein Families |
| 4:00 - 4:40 p.m. | Gary Glick, University of Michigan Chemistry and Biology of Immunosuppressive Benzodiazepines |
| 4:40-5:20 p.m. | Stephen Fesik, Abbott Laboratories NMR-Based Screening of Fragment Libraries for Drug Discovery |
Tuesday, March 16, 2004 | |
| Moderator: John Beutler National Cancer Institute | |
| 8:30 - 9:15 a.m. | Kevan Shokat, University of California, San Francisco Chemical Tools for Deciphering Cell Signaling Pathways |
| 9:15 - 10:00 a.m. | David Diller, Pharmacopeia The Role of Computation When Building Collections of Millions of Compounds |
| 10:00 - 10:45 a.m. | Virginia Cornish, Columbia Co-opting Nature for Chemical Diversity |
| 10:45 - 11:15 a.m. | Break |
| 11:15 - 12:00 p.m. | DimitriusAgrafiotis, 3-Dimensional Pharmaceuticals Molecular Informatics for the New Drug Discovery Enterprise |
| 12:00 - 1:00 p.m. | Lunch |
| Moderator: Carole Bewley, National Institute of Diabetes and Digestive and Kidney Diseases | |
| 1:00 - 1:40 p.m | Chaitan Khosla, Stanford University Discovery and Development of New Natural Product Drugs: The Example of Polyketides |
| 1:40 - 2:20 p.m. | Baldomero Olivera,University of Utah Conus Peptides: From Genes to Venoms to Drugs |
| 2:20 - 3:00 p.m. | Michael Organ, York University New Advances in the Screening of Compound Mixtures |
| 3:00 - 3:20 p.m. | Break |
| 3:20 - 4:00 p.m. | Alan Verkman, University of California, San Francisco Drug Discovery in Academia: CFTR Chloride Channel Inhibitors and Activators for Cystic Fibrosis |
| 4:00 - 4:40 p.m. | Eric Lander, The Broad Institute of MIT and Harvard |
| 4:40 - 5:00 p.m. | Closing Remarks: Alan Guttmacher, Deputy Director, National Institute of General Medical Sciences |